Researcher
Agnieszka Wozniak
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Jul 2006 → 30 Sep 2022
Projects
1 - 9 of 9
- Real-time qPCR platform enhancing research activities within the Laboratory of Experimental Oncology and the Laboratory of Experimental RadiotherapyFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Chicken chorioallantoic membrane (CAM) model as a research tool complementary to patient-derived xenografts (PDX) for preclinical drug testing in sarcomas.From1 Oct 2022 → TodayFunding: BOF - projects
- Preclinical evaluation of innovative cytotoxic drugs for the treatment of soft tissue sarcomaFrom28 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring the biology of translocation-related sarcomas and impact on the research for new therapy options.From1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- CYTOTOXIC THERAPY REVISED: EXPLORATION OF INNOVATIVE (PRO)DRUGS IN PATIENT-DERIVED XENOGRAFTS OF SOFT TISSUE SARCOMAFrom1 Sep 2018 → 25 Oct 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of soft tissue sarcoma and the potential clinical applicationsFrom26 Sep 2017 → 25 Feb 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Clinical outcome, Pathological results and immunohistochemical findings of rare subtypes of soft tissue sarcomasFrom10 Aug 2015 → 30 Sep 2017Funding: Nonprofit institution or equivalents
- Establishment of new research models and in vivo efficacy testing of novel treatment strategies for resistant gastrointestinal stromal tumorsFrom1 Aug 2014 → 19 May 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting soft tissue sarcoma with smart molecules - exploring cytotoxic prodrugs and target-specific inhibitors in patient-derived xenograftsFrom1 Aug 2013 → 30 Nov 2017Funding: Nonprofit institution or equivalents
Publications
91 - 100 of 107
- Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans.(2011)
Authors: Agnieszka Wozniak
Pages: 959132 - Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - The impact of tumour rupture on patient outcomes(2011)
Authors: Agnieszka Wozniak
Pages: 890 - 896 - Retroperitoneal Dedifferentiated Liposarcomas with Production of β-Human Chorionic Gonadotropin - a Distinct Sarcoma Entity?(2011)
Authors: Patrick Schöffski, Kathleen Forceville, Maria Debiec-Rychter, Agnieszka Wozniak, Raf Sciot
Pages: 122 - 5 - Implications of Mutational Analysis for the Management of Patients With Gastrointestinal Stromal Tumors and the Application of Targeted Therapies(2010)
Authors: Agnieszka Wozniak, Beppe Floris, Maria Debiec-Rychter, Raf Sciot, Patrick Schöffski
Pages: 839 - 848 - Coactivated Platelet-Derived Growth Factor Receptor alpha and Epidermal Growth Factor Receptor Are Potential Therapeutic Targets in Intimal Sarcoma(2010)
Authors: Barbara Dewaele, Beppe Floris, Agnieszka Wozniak, Patrick Schöffski, Peter Marynen, Peter Vandenberghe, Raf Sciot, Maria Debiec-Rychter
Pages: 7304 - 7314 - Co-activated PDGFRA and EGFR are potential therapeutic targets in intimal sarcoma(2010)
Authors: Barbara Dewaele, Beppe Floris, Julio Finalet-Ferreiro, Christopher Fletcher, Jean Michel Coindre, Louis Guillou, Pancras C Hogendoorn, Agnieszka Wozniak, Vanessa Vanspauwen, Patrick Schöffski, et al.
Pages: 7304 - 7314 - EGFR, PIK3CA and PTEN gene status and their protein product expression in neuroblastic tumours(2010)
Authors: Agnieszka Wozniak
Pages: 238 - 245 - MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema(2010)
Authors: Patrick Schöffski, Raf Sciot, Agnieszka Wozniak
Pages: 34 - 39 - Prognostic significance of HER2 expression in neuroblastic tumors(2010)
Authors: Agnieszka Wozniak
Pages: 1261 - 1268 - High Efficacy of Panobinostat Towards Human Gastrointestinal Stromal Tumors in a Xenograft Mouse Model(2009)
Authors: Beppe Floris, Maria Debiec-Rychter, Raf Sciot, Steffen Fieuws, Kathleen Machiels, Agnieszka Wozniak, Patrick Schöffski
Pages: 4066 - 4076